Document is current
Any future updates will be listed below
-
Authors
Welikovitch, Lindsay A.
Oakley, Derek H.
Bennett, Rachel E.
Serrano-Pozo, Alberto
Zhu, Haoyang
Ruiz-Uribe, Nancy E.
Zwang, Theodore J.
Chibnik, Lori B.
Gomez-Isla, Teresa
Frosch, Matthew P.
Marks, Donald S.
Salloway, Stephen
Bernick, Charles
Greeley, David
Latimer, Caitlin S.
Nolan, Amber
Hutchison, R. Matthew
Rubel, Carrie E.
Bussiere, Thierry
Plowey, Edward D.
Keene, C. Dirk
Hyman, Bradley T.
-
Funding
Funding for this research was provided by:
Alzheimer's Association (24AARF-1192364)
National Institutes of Health (R01AG071567)
National Institutes of Health (UW ADRC P30 AG066509)
Massachusetts Alzheimer Disease Research Center (P30AG062421)
US Department of Defense (W81XWH-21-S-TBIPH2)
Allen Institute for Brain Science
Nancy Buster Alvord Endowment
Weill Neurohub Investigator program
Freedom Together Foundation
- License Information
-
More Information
Article History
Received: 3 March 2026
Revised: 7 May 2026
Accepted: 25 May 2026
First Online: 16 June 2026
Declarations
:
: SS is a consultant for Amylyx, Alnylam, Biogen, Bolden, Eisai, Eli Lilly, Genentech, NovoNordisk, Ono, Prothena, and Roche. CB serves on the scientific advisory board for NovoNordisk. DG was the Chief Medical Officer for AriBio from 2023–2024. RMH is an employee and shareholder of Biogen. CER is an employee and shareholder of Biogen. TB is a former employee and shareholder of Biogen. EDP is an employee and shareholder of Biogen. BTH serves on a scientific advisory board or is a consultant for AbbVie, Alexion, Ambagon, Aprinoia Therapeutics, Arbor Bio, Arvinas, Avrobio, AstraZenica, Biogen, Bioinsights, BMS, Cell Signaling, Cure Alz Fund, CurieBio, Dewpoint, Eisai, Etiome, Latus, Merck, Novartis, Paragon, Pfizer, Sanofi, Sofinnova, SV Health, Takeda, TD Cowen, Vigil, Violet, Voyager, WaveBreak; his laboratory is supported by research grants from the National Institutes of Health, Cure Alzheimer’s Fund, Tau Consortium, and the JPB Foundation—and a sponsored research agreement from Abbvie and Sanofi; he has a collaborative project with Biogen and Neurimmune AG.
